CCEL Stock Analysis: Buy, Sell, or Hold?
CCEL - Cryo-Cell International Inc.
$3.34
0.06 (1.83%)
▲
5d:
-13.02%
30d:
-5.92%
90d:
-5.92%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Jul 21, 2026
16d
Get Alerted When CCEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CCEL is down 13.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CCEL is down 13.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CCEL is currently trading at $3.34, which is considered slightly low relative to its 30-day fair value range of $3.29 to $3.76. The stock's valuation (Forward PE: 167.0) is in line with its historical norms (177.3). Remarkably, the market is currently pricing in an annual earnings decline of 2.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CCEL is in a uptrend. Immediate support is located at $2.90, while resistance sits at $4.05.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.50 (+154.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CCEL is in a uptrend. Immediate support is located at $2.90, while resistance sits at $4.05.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.50 (+154.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.29 -
$3.76
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 154.5% below Wall St target ($8.50)
- WARNING: Recommendation downgraded due to -13.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$3.29 -
$3.76
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.90
Resistance Level
$4.05
Current Trend
Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
167.00
Wall Street Target
$8.50
(+154.5%)
Revenue Growth (YoY)
-3.6%
Earnings Growth (YoY)
-80.5%
Profit Margin
-8.5%
Valuation Discount vs History
-2.0% cheaper
PE vs Historical
167.0 vs 177.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.0%
(market-implied from PE analysis)
1-Year Target
$3.27
(-2%)
2-Year Target
$3.21
(-4%)
3-Year Target
$3.14
(-6%)
3-Yr Target (if PE normalizes)
(PE: 167→177)
$3.34
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 167.0, Growth: -81.8%)
$2.43
(+-27%)
Base:
(SPY PE: 21.8, Growth: -81.8%)
$0.32
(-91%)
Bear:
(PE: 18.5, Growth: -81.8%)
$0.27
(-92%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 167.0 to 177.3
Stabilization Target:
$3.55
(+6.2%)
PE Expansion Potential:
+6.2%
Share & Embed Analysis
Last updated: July 03, 2026 7:13 PM ET
Data refreshes hourly during market hours. Next update: 8:13 PM
Data refreshes hourly during market hours. Next update: 8:13 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$243 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$500 | 66 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 58 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 53 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 60 BUY |
